2019 US Drugs of Abuse Testing Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review

This new 278-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.


Introduction
Market and Technology Overview
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
E. Market Size, Growth and Major Instrument
and Reagent Suppliers Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition

D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Strategies
- Abbott Laboratories
- AdnaGen
- Agilent Technologies
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio/Innogenetics
- Grifols
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE

List Of Tables


Major Companies Developing or Marketing
Drugs of Abuse Tests
U.S.A., Drugs of Abuse Test Volume
Forecast By Market Segment
U.S.A., All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Test Volume Forecast
by Assay
U.S.A., Drugs of Abuse Reagent Market
Forecast By Market Segment by Assay
U.S.A., All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., Physician Offices/Group Practices,
Drugs of Abuse Reagent Market Forecast
by Assay
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization

U.S.A., Hospital Emergency Departments
Drugs of Abuse Test Volume Forecast

U.S.A., Hospital Emergency Departments
Drugs of Abuse Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers
Drugs of Abuse Test Volume Forecast
U.S.A., Ambulatory Care Centers
Drugs of Abuse Reagent and Instrument Sales Forecast
U.S.A., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares

Global Human Milk Oligosaccharides Market – Trends & Forecast, 2019-2025

Human Milk Oligosaccharides Market Research Report - Global Forecast till 2025Global Human Milk Oligosaccharides Market Information: Information by Type (Neutral and Acidic), Application (Food Industry and Laboratory Research) and Region

USD 4450 View Report

Canada Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review, 2019-2023

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2750 View Report

Global Human Respiratory Syncytial Virus Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities

The Human Respiratory Syncytial Virus Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is

USD 2950 View Report

US Drugs of Abuse Testing Market for 12 Assays, 2019-2023: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

This new 262-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available